XPC rs2228001 genotype has also been found to correlate with survival of hepatocellular patients [66], with XPC mRNA expression levels [60,66,67], with drug-induced toxicity in cancer patients treated with platinum-based chemotherapeutic agents (e.g., cisplatin) [68,69], with sensitivity of lung squamous cell carcinoma patients to chemotherapy [67] and to interfere with the capacity to repair DNA lesions induced by, e.g., benzo(a)pyrene [70,71,72], gamma-radiation [70], X-rays [73], UV radiation [74], aflatoxin B1 [50] and meat-derived carcinogens [75]. The gene discussed is XPC; the disease is cancer.